Bordner, Jon published the artcile1,3-Diamino-6,7-dimethoxyisoquinoline derivatives as potential α1-adrenoceptor antagonists, COA of Formula: C10H17N3O2, the publication is Journal of Medicinal Chemistry (1988), 31(5), 1036-9, database is CAplus and MEDLINE.
Treatment of 2,4,5-Me(MeO)2C6H2CN (I) with LiN(CHMe2)2 followed by reaction with R2NCN [R = Me, R2 = (CH2)5] provided 1,3-diamino-6,7-dimethoxyisoquinolines II (R = as above), which were evaluated for α-adrenoceptor binding affinity and antihypertensive activity. II (R = Me) showed no significant affinity for α1-adrenoceptors, while the 3-(2-furoyl-1-piperazinyl) analog III, prepared from I and 1-cyano-4-(tert-butoxycarbonyl)piperazine in 3 steps, was 1000-fold less potent than prazosin. PKa data showed that 34% N(2) protonation of II (R = Me) (pKa = 7.1) would occur at physiol. pH, in agreement with x-ray crystallog. anal. of III.HCl. Comparison of pos. charge distribution following protonation of II (R = Me) with the corresponding quinoline and quinazoline cations confirmed that N(1) protonation is required for these heterocyclic nuclei to bind efficiently to the α1-adrenoceptor. Computer-assisted comparison of the x-ray structures of III.HCl and prazosin suggested that the 4.0 kcal/mol difference in α1-adrenoceptor binding energies was largely due to salt-bridge formation (ca. 3.0 kcal/mol) between the protonated quinazoline and the receptor protein. Neither II nor III were effective antihypertensive agents in rats even when administered at relatively high doses (10 mg/kg). These results support the hypothesis that the antihypertensive activity of prazosin, doxazosin, and related compounds derives solely from α1-adrenoceptor blocking.
Journal of Medicinal Chemistry published new progress about 113534-02-4. 113534-02-4 belongs to piperazines, auxiliary class Piperazine,Nitrile,Amide, name is tert-Butyl 4-cyanopiperazine-1-carboxylate, and the molecular formula is C10H17N3O2, COA of Formula: C10H17N3O2.
Referemce:
https://en.wikipedia.org/wiki/Piperazine,
Piperazines – an overview | ScienceDirect Topics